From Opium to Opioids: A Comparative Historical Analysis of Drug Crises in Qing Dynasty China and Contemporary United States

Daihun Kang; Myung Jo Kim

doi:10.20944/preprints202409.2168.v1

Submitted:

26 September 2024

Posted:

27 September 2024

You are already at the latest version

Abstract

Background: This study conducts a comparative historical analysis of two significant drug crises: the opium epidemic in 19th-century Qing Dynasty China and the ongoing opioid crisis in the United States, aiming to extract applicable lessons for current global drug policies. Methodology: A historical case study approach was employed, integrating examinations of historical records, policy documents, and contemporary data to compare the development, impact, and responses to these crises within their respective contexts. Results: The analysis reveals significant parallels in socioeconomic impacts and governmental challenges. Key differences include the evolution from predominantly prohibitionist approaches in Qing China to more comprehensive public health-oriented strategies in the U.S. The study highlights the critical role of national power, particularly military capability, in effectively addressing drug crises. Conclusions: The findings underscore four key lessons: (1) Purely prohibitionist approaches often lead to unintended consequences such as black markets and increased criminal activity; (2) Addressing underlying socioeconomic factors contributing to drug abuse is crucial; (3) Aggressive anti-drug policies can escalate into severe diplomatic tensions, necessitating careful consideration of international relations in policy formulation; (4) A nation's military and economic strength significantly influences its ability to implement effective drug policies and resist external pressures that may exacerbate the crisis. These insights suggest that effective management of drug crises requires a balance of strong domestic policies, international cooperation, and maintenance of national power to ensure policy autonomy.

Keywords:

opium crisis

;

opioid epidemic

;

Qing Dynasty

;

United States

;

drug policy

;

historical comparison

;

national power

;

military influence

;

public health

;

international relations

Subject:

Public Health and Healthcare - Health Policy and Services

Introduction

Across centuries and continents, drug epidemics have recurrently emerged as powerful forces, re-shaping societies and exposing vulnerabilities in governance and public health [1]. This study undertakes a comparative historical analysis of two significant drug crises: the opium epidemic in 19th-century Qing Dynasty China [2,3] and the ongoing opioid crisis in the United States [4]. Despite being separated by time and geography, these crises reveal striking parallels that offer valuable insights for contemporary drug policy and underscore the cyclical nature of such epidemics.

In the mid-19th century, the Qing Dynasty faced unprecedented societal and economic turmoil due to the massive influx of opium, leading to widespread addiction [5]. This crisis not only precipitated the Opium Wars but also fundamentally altered China's relationship with Western powers, contributing to the dynasty's eventual decline [6,7]. The repercussions extended far beyond public health, eroding national sovereignty and leaving an indelible mark on China's modern history [8].

In contrast, the current opioid epidemic in the United States, which originated in the late 20th century through the misuse of prescription drugs [4,9], has escalated into a public health emergency of unparalleled scale. The rising tide of overdose deaths and profound socioeconomic impacts have exposed deep vulnerabilities within one of the world's most expensive healthcare systems and posed significant challenges to the nation's social fabric.

This study seeks to explore the development of these crises within their respective historical, social, and economic contexts. By juxtaposing the Qing Dynasty's opium crisis with the current U.S. opioid crisis, this research aims to identify recurring patterns in the evolution of drug epidemics and assess the efficacy of various response strategies. The main research questions guiding this analysis are:

What are the historical, social, and economic parallels and distinctions between the opium crisis in Qing Dynasty China and the opioid crisis in contemporary United States?
How did each country's response strategies differ, and what were the outcomes?
What lessons can be drawn from the Qing Dynasty's experience that are applicable to current global drug policies?
How do national power dynamics, including military capabilities, and international relations shape the trajectory and management of drug crises?

This comparative analysis is significant for several reasons. First, it situates current debates on drug policy within a broader historical context, offering potential guidance for addressing the ongoing opioid crisis. Second, by identifying similarities and differences between these crises, we can better understand the recurrent nature of drug epidemics and the societal responses they elicit. Third, this research bridges the gap between historical scholarship and contemporary policy discussions, contributing to a more nuanced understanding of drug crises across diverse cultural and temporal landscapes. Finally, it examines the role of national power and international relations in influencing both the crises themselves and the responses, offering insights into the geopolitical dimensions of drug epidemics.

Employing a historical case study approach focused on comparative analysis, this study integrates examinations of historical records, policy documents, and contemporary data. Through this approach, we aim to extract lessons from the past that can inform current and future strategies for combating drug epidemics.

The findings of this research hold significant implications for policymakers, public health officials, and global leaders grappling with the current opioid crisis. By drawing from historical parallels and understanding the complex interplay of factors involved, we can navigate the challenges posed by drug crises in the 21st century with greater foresight and effectiveness.

It is important to note, however, that this study has limitations. The vast differences in cultural, technological, and geopolitical contexts between 19th-century China and contemporary United States may limit direct comparisons. Additionally, the availability and reliability of historical data from the Qing Dynasty era may constrain certain aspects of the analysis. Despite these limitations, this comparative study offers valuable insights into the enduring challenges of drug epidemics and the complex interplay of factors that shape their trajectories and societal responses.

Methods

This study employs a historical case study approach to compare two significant drug crises: the Opium Crisis in 19th-century Qing Dynasty China and the ongoing Opioid Crisis in the United States. This methodology allows for an in-depth exploration of each crisis within its historical and social context.

Data Collection:

Literature Review: A comprehensive review of academic literature, historical texts, and contemporary reports was conducted using databases such as PubMed, JSTOR, and Google Scholar. Key search terms included "opium crisis," "Qing Dynasty," "opioid epidemic," and "United States."
Historical Documents: For the Qing Dynasty crisis, historical records and government documents were examined to provide context and primary source information.
Contemporary Sources: For the U.S. opioid crisis, current public health reports, government publications, and reputable news articles were reviewed.

Data Analysis:

1.: Comparative Analysis: The study identified and compared the main similarities and differences between the two crises, focusing on:

Socioeconomic impacts
Government responses
Public health strategies

2.: Thematic Analysis: Through careful reading and review of the collected literature, recurring themes and patterns were identified manually, without the use of specialized software.
3.: Historical Context Analysis: The historical, social, and political contexts of each crisis were analyzed to understand how they influenced the development and impact of the drug epidemics.

Ethical Considerations: This study relied on publicly available data and historical documents, not involving human subjects, thus not requiring ethical approval. All sources were properly cited to maintain academic integrity.

This streamlined approach allows for a thorough comparison of the two crises while remaining practical and achievable within the constraints of the study. It provides valuable insights into the similarities and differences between historical and contemporary drug crises, potentially informing current policy and public health strategies.

Results

Our comprehensive analysis of the Opium Crisis in 19th-century Qing Dynasty China and the contemporary Opioid Crisis in the United States revealed profound insights into the nature, impact, and responses to major drug epidemics across different historical contexts (Table 1).

Descriptive Overview

1.1: Opium Crisis in Qing Dynasty China:

Substance: Primarily opium derived from poppies, both imported and domestically cultivated [3,10,11].
Socioeconomic Context: Occurred when China was the world's largest economy, deeply affecting its social fabric and economic stability [12].
Extent: Widespread addiction, especially among working-age males, leading to reduced productivity and economic instability [10,13].
Government Response: Initially characterized by regulation attempts, later shifting to strict prohibition policies implemented by Commissioner Lin Zexu [14].
Outcome: Led to the Opium Wars, resulting in China's defeat, significant loss of sovereignty, and imposition of unequal treaties, including the legalization of opium trade [15,16].

1.2: Contemporary U.S. Opioid Crisis:

Substance: Evolution from prescription opioids (e.g., OxyContin) to heroin and synthetic opioids, particularly fentanyl [17,18,19].
Socioeconomic Context: Unfolding in the world's largest economy, causing widespread addiction and increasing mortality rates [9,20,21].
Extent: Nationwide crisis with severe impacts on public health, particularly in rural and economically disadvantaged areas [4,22,23].
Government Response: Multi-faceted approach encompassing prevention, treatment, law enforcement, and legal action against pharmaceutical companies [24].
Current Status: Ongoing crisis with escalating public health concerns and socioeconomic challenges [24,25,26].

2.: Comparative Analysis

2.1. Similarities:

Economic Significance: Both crises occurred in globally dominant economies, highlighting the vulnerability of even the most powerful nations to drug epidemics.
Nationwide Impact: Each crisis permeated all levels of society, causing significant social disruption and economic strain.
International Dimensions: Both involved complex international relations and trade conflicts, demonstrating the global nature of drug crises.

2.2. Differences:

Substance Characteristics: Natural opium in Qing China vs. more potent synthetic opioids in the U.S., reflecting technological advancements in drug production [18].
Government Strategies: Evolution from predominantly prohibitionist approaches in Qing China to a more comprehensive public health-oriented strategy in the U.S.
Public Health Response: Minimal health initiatives in Qing China [27] contrasted with extensive treatment programs and harm reduction strategies in the U.S., indicating advancements in medical understanding and public health policies [28].
National Power and Policy Implementation: The Qing Dynasty's military inferiority significantly hampered its ability to enforce anti-opium policies and resist foreign pressure [29]. In contrast, the U.S.'s global military and economic power allows for more effective policy implementation and international cooperation in addressing the opioid crisis [30] (Table 2).

3.: Thematic Analysis

3.1. Recurring Themes:

Economic Dependency: Both crises were exacerbated by the profitability of the drug trade and economic vulnerabilities of affected populations.
Social Disintegration: Widespread addiction led to family breakdowns, increased crime, and community disruption in both eras [23,31].
Ineffectiveness of Initial Government Responses: Both governments initially underestimated the severity of the crises, leading to delayed and, at times, ineffective responses.
Policy Evolution: Progression from purely punitive measures to incorporating public health strategies, reflecting a growing understanding of addiction as a health issue [1,24,25].
National Sovereignty and Crisis Management: The Qing Dynasty's diminished sovereignty due to military defeats severely limited its ability to control the opium crisis ⁷. The U.S., maintaining strong national sovereignty, faces different challenges in addressing its opioid crisis, primarily related to domestic policy and international cooperation rather than external military threats [17].
Military Defeat and Drug Policy: The Qing Dynasty's military defeats in the Opium Wars directly led to the legalization and spread of opium, demonstrating how military weakness can compromise a nation's ability to implement effective drug policies and protect public health [6,7].

4.: Historical Context Analysis

4.1. Qing Dynasty:

The crisis unfolded against a backdrop of China's declining global influence and internal instability [2,16].
Limited scientific understanding of addiction and lack of modern public health infrastructure hampered effective responses [32,33].
Military defeats in the Opium Wars not only weakened China's sovereignty but also forced the legalization of opium trade [16]. The Treaty of Tientsin after the Second Opium War (1856-1860) officially legalized opium importation [34].
Economic pressures resulting from war reparations led the Qing government to tax the opium trade, inadvertently perpetuating the addiction crisis for the sake of government revenue [35].

4.2. United States:

The crisis emerged in an era of advanced medical knowledge but complex socioeconomic challenges.
The global leadership position of the U.S., including its military strength, influences its approach to the crisis, particularly in terms of international drug trafficking interdiction and global cooperation [9].
Modern public health infrastructure allows for more comprehensive strategies, yet challenges persist in addressing the illegal drug trade and ensuring adequate treatment resources [1,24].

Summary of Key Findings:

Despite occurring in vastly different times and cultures, both crises share significant similarities in their socioeconomic impacts and the challenges faced by governments in addressing them.
The U.S. crisis benefits from modern public health infrastructure and understanding, yet both crises demonstrate the difficulty of overcoming widespread drug addiction once it has taken hold in society.
The evolution of response strategies from the Qing Dynasty to modern U.S. reflects advancements in medical understanding, public health approaches, and global interconnectedness.
Analysis of the Qing Dynasty's response offers valuable insights for current and future public health strategies in combating drug epidemics:

①

It highlights the limitations of purely prohibitionist approaches, which can lead to unintended consequences such as the creation of black markets and increased criminal activity.

➁

It emphasizes the importance of addressing underlying socioeconomic factors that contribute to drug abuse and addiction.

➂

The Qing experience demonstrates how aggressive anti-drug policies, especially when implemented in a context of international trade disputes, can escalate into severe diplomatic tensions and even warfare. This underscores the need for careful consideration of international relations and diplomacy in drug policy formulation.

➃

It illustrates the potential for drug crises to become intertwined with broader geopolitical conflicts, highlighting the need for a nuanced approach that balances domestic public health concerns with international diplomatic considerations.

The role of national power, particularly military capability, in shaping a nation's ability to address drug crises is significant. The Qing Dynasty's experience demonstrates how military inferiority and subsequent political concessions can exacerbate a public health crisis, while the U.S.'s strong position allows for more effective policy implementation and international cooperation.
The Qing Dynasty's experience illustrates how military defeats can directly impact drug policy and public health. The legalization of opium trade after military losses, driven by economic necessity, demonstrates how external pressures can force a nation to make decisions that have long-term detrimental effects on public health.
The contrast between the Qing Dynasty's forced policy changes due to military defeat and the United States' ability to maintain policy autonomy highlights the crucial role of national strength in addressing drug crises effectively.

These results underscore the enduring and evolving nature of drug crises across different historical periods, emphasizing the need for nuanced, multifaceted approaches that consider both historical lessons and contemporary contexts in addressing drug epidemics. The analysis highlights how a nation's overall strength, including its military capabilities, economic decisions, and international standing, can significantly influence its ability to manage and overcome such crises.

Discussion

The comparative analysis of the Opium Crisis in 19th-century Qing Dynasty China and the contemporary Opioid Crisis in the United States reveals enduring patterns and critical lessons for understanding and addressing drug epidemics across different historical contexts. This discussion delves into these patterns, their implications for current and future drug policies, and the potential consequences of various approaches to managing these crises.

Historical Patterns and Modern Implications

Our analysis suggests that drug crises are not merely products of their time but recurring phenomena that transcend technological advancements and shifts in global power dynamics. From the opium epidemic in Qing China to the opioid crisis in modern America, these crises are deeply embedded in complex socio-economic and political structures. This recurrence highlights that drug epidemics are far more than law enforcement or public health challenges; they are systemic issues that reflect deeper societal vulnerabilities.

One unavoidable outcome of stringent drug prohibition policies is the emergence of black markets. Both the Qing Dynasty and the United States have encountered this reality. These black markets, often crossing national borders, transform drug crises into international issues, escalating diplomatic tensions and, in some cases, sparking military conflicts.

The Potential for International Conflict and the Role of Military Power

History teaches us that when severe drug crises intersect with strong nationalist sentiments and strict enforcement policies, the risk of international conflict increases significantly. The Opium Wars are a stark reminder of how drug-related disputes can escalate into full-scale wars. In today’s context, similar tensions could arise between the United States and nations implicated in the production or trafficking of opioids, such as China or certain Latin American countries.

The Qing Dynasty’s military inferiority severely hampered its ability to enforce anti-opium policies and resist foreign pressure [7,16]. This historical weakness underscores the importance of national power in managing such crises. In contrast, the United States’ current global military and economic strength provides it with considerable leverage in international anti-drug efforts. However, this advantage is not absolute; any significant erosion of U.S. power could severely undermine its ability to combat the opioid crisis effectively.

A hypothetical scenario where the United States faces a defeat in a drug-related conflict, particularly against a resurgent China under the leadership of Xi Jinping, General Secretary of the Chinese Communist Party and President of the People's Republic of China, could have dire consequences. China, now the world's second-largest economy and a major military power, has been asserting its global influence more aggressively. Given China's official stance on reunification with Taiwan and increasing tensions in the South China Sea, the probability of a military confrontation between China and the United States in the near future has significantly increased.

In such a scenario, a U.S. defeat could potentially lead to unchecked drug proliferation across the American continent. This could be exacerbated if China, leveraging its victory, were to tacitly support or fail to adequately control the flow of precursor chemicals and synthetic opioids to the Americas [9,18,36,37]. The resulting rapid societal decline could severely impact U.S. institutions, public health, and national security, mirroring in some ways the consequences faced by Qing Dynasty China following the Opium Wars.

Moreover, this hypothetical defeat could dramatically alter the global balance of power, potentially emboldening other nations or non-state actors involved in drug trafficking. The repercussions could extend far beyond drug policy, affecting international trade, diplomatic relations, and geopolitical stability worldwide, reminiscent of the far-reaching impacts of the 19th-century opium crisis.

While this scenario is speculative, it serves a crucial analytical purpose. It underscores the complex interplay between drug policies, international relations, and national security in our increasingly interconnected world. This perspective highlights the importance of addressing drug crises not just as public health issues, but as matters of national security and global stability. By drawing these parallels between historical events and potential future scenarios, we gain valuable insights into the multifaceted nature of drug epidemics and their profound geopolitical implications.

The Emergence of Strong Leadership and Its Impact

Severe drug crises often give rise to strong, patriotic leaders who advocate for strict control measures. Commissioner Lin Zexu in Qing China exemplifies this phenomenon [38]. His unwavering determination to eradicate opium from China, despite the overwhelming challenges, reflects a form of patriotic fervor that can rally a nation [14,38].

In the United States, it is conceivable that a similar leader could emerge, advocating for aggressive policies against nations perceived as enablers of the drug trade. While such leadership may be necessary to address the crisis decisively, it also carries the risk of escalating international tensions, potentially leading to military conflict.

The Need for Balanced Policy Approaches

While the potential for strict enforcement and international conflict is significant, our analysis also highlights the limitations of a purely prohibitionist approach. The evolution of drug policies from the Qing Dynasty to modern America shows a growing recognition of addiction as a complex public health issue that requires a multifaceted response.

To effectively combat drug crises, strategies must balance strong enforcement with comprehensive public health initiatives and address the underlying socio-economic factors that drive addiction. This includes implementing evidence-based prevention and treatment programs, addressing the socio-economic conditions that contribute to drug abuse, and enhancing international cooperation in combating drug trafficking. Moreover, investing in research to better understand addiction and develop effective interventions is crucial.

The Importance of National Capacity and International Cooperation

Our findings underscore the critical importance of a nation’s economic and military power in effectively addressing drug crises. However, they also highlight the indispensable role of international cooperation and diplomatic finesse. The global nature of the modern drug trade requires collaborative efforts among nations to tackle both the supply and demand sides of the equation.

Countries must invest in building robust public health infrastructure and social support systems to address the demand side of drug abuse. This dual approach—combining international efforts to curtail the drug supply with domestic initiatives to reduce demand and mitigate harm—represents the most promising path forward.

Conclusion

The comparative study of the Qing Dynasty's Opium Crisis and the current U.S. Opioid Crisis reveals enduring patterns in the emergence, escalation, and management of drug epidemics. While historical parallels suggest the potential for severe international conflicts arising from drug crises, they also emphasize the need for nuanced, multifaceted approaches that consider both domestic and international dynamics.

As nations continue to grapple with drug crises, policymakers must remain mindful of these historical lessons. The emergence of strong, nationalist leadership in response to drug crises must be carefully balanced against the need for international cooperation and evidence-based public health strategies. Additionally, maintaining national strength—both economic and military—appears crucial in effectively managing these crises and preventing potentially catastrophic outcomes.

Ultimately, addressing drug epidemics requires a delicate balance between assertive policy actions, diplomatic finesse, and compassionate public health measures. As global dynamics evolve, nations must remain vigilant and adaptable in their approaches to drug crises, learning from historical precedents while innovating to meet the unique challenges of the modern era. The stakes are high; failure could lead to societal collapse or international conflict. However, by adopting comprehensive, balanced strategies, there is hope for effectively managing and ultimately overcoming these persistent challenges.

Funding

This research received no external funding.

Data Availability Statement

This study is based on an analysis of publicly available historical documents, academic literature, and contemporary public health reports. No new data were generated or analyzed in the course of this research. The historical data related to the Opium Crisis in Qing Dynasty China are available through various public archives and libraries specializing in Chinese history. Information on the contemporary U.S. Opioid Crisis was obtained from publicly accessible government health databases and published academic research. All sources used in this study are cited in the reference list. Due to the nature of this research, readers are encouraged to refer to these citations for access to the original data sources. Any additional information or clarification regarding the data used in this study can be obtained from the corresponding author upon reasonable request.

Conflicts of Interest

The authors have no financial conflicts of interest to declare.

References

Csete, J.; et al. Public health and international drug policy. The Lancet 2016, 387, 1427–1480. [Google Scholar] [CrossRef] [PubMed]
Lu, L.; Fang, Y.; Wang, X. Drug abuse in China: past, present and future. Cellular and molecular neurobiology 2008, 28, 479–490. [Google Scholar] [CrossRef] [PubMed]
Kaufman, A.A. The “Century of Humiliation” and China’s National Narratives. Testimony before the US-China Economic and Security Review Commission Hearing on China’s Narratives Regarding National Security Policy. Extracted the 2011, 28.
Wilkerson, R.G.; Kim, H.K.; Windsor, T.A.; Mareiniss, D.P. The opioid epidemic in the United States. Emergency Medicine Clinics 2016, 34, e1–e23. [Google Scholar] [CrossRef] [PubMed]
Murakami, E. The Opium Trade and the Transformation of the Maritime Trade System in Pre-Opium War China: A Reexamination. Modern Asian Studies Review 2013, 4, 31–58. [Google Scholar]
Hanes III, W.T. Opium Wars; Sourcebooks, Inc., 2002. [Google Scholar]
Mao, H. The Qing Empire and the Opium War; Cambridge University Press, 2016. [Google Scholar]
Zheng, Y. The Social Life of Opium in China, 1483–1999. Modern Asian Studies 2003, 37, 1–39. [Google Scholar] [CrossRef]
Pergolizzi, J.; Magnusson, P.; LeQuang JA, K.; Breve, F.; Pergolizzi, J., Jr. Illicitly manufactured fentanyl entering the United States. Cureus 2021, 13. [Google Scholar] [CrossRef]
Lu, L.; Wang, X. Drug addiction in China. Annals of the New York Academy of Sciences 2008, 2008, 1141, 304–317. [Google Scholar] [CrossRef]
Dikötter, F.; Laamann, L.P.; Xun, Z. Narcotic culture: a history of drugs in China; Hong Kong University Press, 2004. [Google Scholar]
Zelin, M. Perspectives on Modern China; Routledge, 2016; pp. 31–67. [Google Scholar]
Keller, W.; Shiue, C.H. The economic consequences of the opium war; National Bureau of Economic Research, 2021. [Google Scholar]
Madancy, J.A. The troublesome legacy of Commissioner Lin: the opium trade and opium suppression in Fujian Province, 1820s to 1920s; Harvard Univ Asia Center, 2003; Vol. 227. [Google Scholar]
Sweeney, L. Representations of Western Opium Consumption in China: Informal Empire, Medicine and Modernity, 1840–1930. Social History of Medicine 2023, 36, 386–408. [Google Scholar] [CrossRef]
Suwanthanin, W.; Lakkhongkha, K.; Kato, K. Closed-Door Policy of the Qing Dynasty and China’s Defeat in the First Opium War. Journal of ASEAN PLUS Studies 2022, 3, 1–12. [Google Scholar]
Dasgupta, N.; Beletsky, L.; Ciccarone, D. Opioid crisis: no easy fix to its social and economic determinants. American journal of public health 2018, 108, 182–186. [Google Scholar] [CrossRef]
Hamilton, C.K. America’s Failing Trade War With China: A Focus on Fentanyl. American Journal of Trade and Policy 2021, 8, 59–70. [Google Scholar] [CrossRef]
Compton, W.M.; Jones, C.M.; Baldwin, G.T. Relationship between nonmedical prescription-opioid use and heroin use. New England Journal of Medicine 2016, 374, 154–163. [Google Scholar] [CrossRef] [PubMed]
Broadhurst, R.; Ball, M.; Jiang, C.; Wang, J.; Trivedi, H. Impact of darknet market seizures on opioid availability. 2021.
DEA Washington, D.D.P.I.O. New, dangerous synthetic opioid in DC, emerging in Tri State area. 2022. Available online: https://www.dea.gov/stories/2022/2022-06/2022-06-01/newdangerous-synthetic-opioid-dc-emerging-tri-state-area.
Gardner, E.A.; McGrath, S.; Dowling, D.; Bai, D. The opioid crisis: prevalence and markets of opioids. Forensic Sci Rev 2022, 34, 43–70. [Google Scholar] [PubMed]
Griffith, C.; France, B.L. Socio-Economic Impact on Opioid Addiction Susceptibility. Edelweiss: Psychiatry Open Access, 2018; 1–3. [Google Scholar] [CrossRef]
Kerr, T. Vol. 73 377-378; BMJ Publishing Group Ltd., 2019. [Google Scholar]
Coleman, M.; Connaway, L.S.; Morgan, K. Public libraries respond to the opioid crisis with their communities: Research findings. Collaborative Librarianship 2020, 12, 6. [Google Scholar]
Huber, T.P. Rethinking leadership approaches for community-wide opioid crisis intervention: harnessing positive inquiry to unearth front-line insight. BMJ leader, 2023; leader-2023-000862. [Google Scholar]
Lodwick, K.L. Crusaders against opium: Protestant missionaries in China, 1874-1917; University Press of Kentucky, 2014. [Google Scholar]
Chandler, R.K.; Villani, J.; Clarke, T.; McCance-Katz, E.F.; Volkow, N.D. Addressing opioid overdose deaths: The vision for the HEALing communities study. Drug and Alcohol Dependence 2020, 217, 108329. [Google Scholar] [CrossRef]
Schillinger, N. The Body and Military Masculinity in Late Qing and Early Republican China: The Art of Governing Soldiers; Lexington Books, 2016. [Google Scholar]
Duncan, T.A.; Thomas, A. Opium: The Fuel of Instability in Afghanistan: why the Military Must be Involved in the Solution, and Recommendations for Action; Citeseer, 2007. [Google Scholar]
Altekruse, S.F.; Cosgrove, C.M.; Altekruse, W.C.; Jenkins, R.A.; Blanco, C. Socioeconomic risk factors for fatal opioid overdoses in the United States: Findings from the Mortality Disparities in American Communities Study (MDAC). PLoS One 2020, 15, e0227966. [Google Scholar] [CrossRef]
Xinzhong, Y. Public health in Qing Dynasty Jiangnan: Focusing on environment and water supply. Frontiers of History in China 2007, 2, 379–415. [Google Scholar] [CrossRef]
Xiao, M.; Tang, X. Changes in public health awareness of traditional Chinese medicine in Shanghai in the late Qing Dynasty. Zhong xi yi jie he xue bao= Journal of Chinese Integrative Medicine 2011, 9, 675–680. [Google Scholar] [CrossRef]
Lu, M.-T. THE NEGOTIATIONS OF THE TREATIES OF TIENTSIN OF 1858 (CHINA); The University of Chicago, 1934. [Google Scholar]
Haider, A.; Ali, A.; Zubair, M. Chasing Dragons in the Dragon's Land: A Convoluted Struggle with Drugs and Deviance in Modern China. Asketik: Jurnal Agama dan Perubahan Sosial 2023, 7, 322–343. [Google Scholar] [CrossRef]
Felbab-Brown, V. China's role in the fentanyl crisis; 2023.
Wang, C.; Lassi, N.; Zhang, X.; Sharma, V. The evolving regulatory landscape for fentanyl: China, India, and global drug governance. International Journal of Environmental Research and Public Health 2022, 19, 2074. [Google Scholar] [CrossRef]
Zhang, S.-B.; Wang, P. Exploring the opium prohibition campaign led by LIN Ze-xu, a medical perspective. Zhonghua yi shi za zhi (Beijing, China: 1980) 2013, 43, 101–104. [Google Scholar] [PubMed]

Table 1. Comparative Analysis of the Opium Crisis in Qing Dynasty China and the Contemporary Opioid Crisis in the United States.

Comparison Aspect	Qing Dynasty (19th Century)	Contemporary United States
Main Substance of Addiction	Opium derived from poppies	Synthetic opioids, particularly fentanyl
Economic Rank (Global)	World's largest economy	World's largest economy
Main Trade Routes	Primarily maritime (British-China sea route)	Land and mail (China-US and Latin America-US)
Extent of Spread	Nationwide epidemic causing social and economic issues	Nationwide crisis with increasing rates of addiction and mortality
Government Response Strategy	Strict prohibition policies implemented by Commissioner Lin Zexu	Comprehensive approach: prevention, treatment, and law enforcement
Trade Conflict	Trade surplus with Britain leading to pressure and conflict	Trade tensions exacerbated by the US-China trade war
Outcome of Conflict	Opium Wars resulting in China's defeat and treaty impositions	Ongoing; no conclusive conflict but rising diplomatic tensions
International Cooperation	Limited due to isolationist policies	Attempts at international cooperation, yet challenged by geopolitical tensions
Public Health Initiatives	Minimal; lack of treatment facilities and social programs	Expansion of treatment programs and harm reduction strategies
Social Impact	Social instability and economic decline	Family and community disruption, ongoing public health crisis
Final Results	National devastation and significant loss of sovereignty	Current crisis ongoing; outcome yet to be determined

Table 2. Comparative Analysis of Military Influence on Drug Crisis Management.

Comparison Aspect	Qing Dynasty (19th Century)	Contemporary United States
Military Strength and Influence	Weakened military, vulnerable to foreign invasions	Strong military power, capable of international intervention
International Military Response Capability	Failure in diplomacy and military, leading to loss of sovereignty	Capable of pressuring international drug trafficking networks
Interaction Between Military Power and Drug Policy	Inability to enforce strict drug policies due to military weakness	Comprehensive response strategies supported by military and law enforcement capabilities

Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).

Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.